Table 4.
Descriptive statistics for age, pedometer step-counts and health related outcomes at baseline and week 12 for intervention and control group. Values are mean (M) and standard deviation (SD).
| Intervention Group (n = 39) | Control Group (n = 40) | |||
| Baseline | Week 12 | Baseline | Week 12 | |
| Age (years) | 47.3 (9.3) | a | 51.2 (7.9) | a |
| Steps/day | 6802 (3212) | 9977 (4669) | 6924 (3201) | 7078 (2911) |
| PANAS positive | 31.2 (6.7) | 33.5 (7.4) | 31.7 (6.9) | 31.3 (7.6) |
| PANAS negative | 20.1 (7.2) | 19.1 (6.9) | 20.2 (8.1) | 18.8 (7.5) |
| EQ-5D tariff | 0.88 (0.12) | 0.89 (0.11) | 0.87 (0.12) | 0.89 (0.12) |
| EQ VAS | 65.4 (18.3) | 69.5 (17.8) | 69.8 (19.7) | 70.7 (18.6) |
| Height (m)b | 1.66 (0.08) | a | 1.64 (0.08) | a |
| Body Mass (kg)b | 78.9 (15.6) | 79.1 (15.2) | 79.5 (18.1) | 79.6 (17.8) |
| BMI (kg/m2)b | 28.5 (4.8) | 28.7 (4.8) | 29.4 (6.3) | 29.5 (6.2) |
| Waist circumference (cm)b | 89.5 (12.6) | 89.9 (12.6) | 90.4 (14.6) | 91.1 (15.6) |
| Hip circumference (cm)b | 108.9 (8.8) | 108.6 (9.7) | 110.1 (12.4) | 110.3 (11.8) |
| Waist:Hip Ratiob | 0.82 (0.08) | 0.83 (0.08) | 0.82 (0.09) | 0.82 (0.09) |
| % body fatb | 30.7 (4.4) | 31. (4.9) | 31.8 (5.6) | 32.7 (6.3) |
| Systolic blood pressure (mm Hg)b | 118.2 (17.9) | 119.6 (17.0) | 119.9 (15.9) | 121.9 (15.1) |
| Diastolic blood pressure (mm Hg)b | 75.1 (11.4) | 77.1 (12.1) | 75.5 (11.8) | 79.1 (11.6) |
| Heart Rate (beats.min-1)c | 68.6 (7.2) | 69.8 (7.2) | 67.9 (8.6) | 69.2 (9.0) |
| Total Cholesterol (mmol.l-1)c | 5.4 (1.3) | 5.4 (1.2) | 5.5 (1.1) | 5.5 (1.0) |
| HDL (mmol-1)c | 1.3 (0.3) 50.7 | 1.3 (0.3) | 1.4 (0.4) 54.6 | 1.4 (0.4) |
| Chol:HDL Ratioc | 4.2 (1.1) | 4.2 (1.1) | 4.1 (1.2) | 4.0 (1.3) |
a not measured at week 12.
b anthropometric measures: (n = 37) for intervention group, (n = 39) for control group.
c blood measures: (n = 32) for intervention group, (n = 34) for control group.
Note: there were no significant differences between the intervention and control group for any variable at baseline.